Skip to main content

Research Repository

Advanced Search

Harnessing CRISPR/Cas9 technology in cardiovascular disease (2019)
Journal Article
Rezaei, H., Khadempar, S., Farahani, N., Hosseingholi, E. Z., Hayat, S. M. G., Sathyapalan, T., & Sahebkar, A. H. (in press). Harnessing CRISPR/Cas9 technology in cardiovascular disease. Trends in Cardiovascular Medicine, https://doi.org/10.1016/j.tcm.2019.03.005

The CRISPR/Cas9 system is a precisely targeted bacterial defense system, used to control invading viruses. This technology has many potential applications including genetic changes in somatic and germ cells and the creation of knockout animals. Compa... Read More about Harnessing CRISPR/Cas9 technology in cardiovascular disease.

The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study (2009)
Journal Article
Sathyapalan, T., Kilpatrick, E. S., Coady, A. M., & Atkin, S. L. (2009). The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study. Journal of Clinical Endocrinology and Metabolism, 94(1), (103-108). doi:10.1210/jc.2008-1750. ISSN 0021-972x

CONTEXT: Polycystic ovary syndrome (PCOS) is associated with increased risk of cardiovascular morbidity, whereas statins are proven to reduce cardiovascular mortality and morbidity through lipid-lowering and perhaps through their pleiotropic effects.... Read More about The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study.